Embattled Mylan files Herceptin biosimilar in US
But senators call for investigation into EpiPen schools contracts.
But senators call for investigation into EpiPen schools contracts.
Pfizer taking on J&J’s blockbuster Remicade.
Pfizer’s rival launch should be considered “at risk”, says J&J
Pfizer gearing up for US launch late next month.
Company looks to new drugs as US Remicade competition looms.
FDA approves first near-copy of inflammatory diseases drug.
First Herceptin biosimilar filed in EU, companies say.
Pfizer must wait until 180 day period ends, court fight ongoing.
FDA committee recommends near-copy.